Mankind Pharma Pledges 39.68% Stake in Bharat Serums to Secure ₹5,000 Crore NCDs – What’s Next?
Mankind Pharma Limited, a major player in the pharmaceutical industry, announced on Friday (November 15) through an exchange filing that its wholly owned subsidiary, Bharat Serums and Vaccines Limited (BSV), has pledged 39.68 percent of BSV’s equity shares to Catalyst Trusteeship Limited as security for non-convertible debentures (NCDs) worth Rs 5,000 crores. Pledge Agreement Details … Read more
